Società Italiana
di Fertilità e Sterilità
e Medicina della Riproduzione

direttivo >>>

Paola Anserini

Paola Anserini

Titoli di Studio

1985 Laurea in Medicina e Chirurgia presso l’Università di Genova

1988 Specializzazione in Patologia della Riproduzione Umana presso l’Università di Genova

1992 Specializzazione in Ginecologia e Ostetricia presso l’Università di Genova

1997 Dottorato di ricerca in Bioetica

Attività Lavorativa

Anni accademici 85/86, 86/87, 87/88 borsista (borse di studio annuali per specializzandi, banditi dalla regione Liguria).

Dal 1985, anno in cui è stato eseguito il primo intervento di Procreazione Medicalmente Assistita (PMA), fa parte dell’équipe che si occupa della diagnosi e della terapia della sterilità di coppia nell’Istituto di Ostetrica e Ginecologica dell’Università di Genova.

Dal 1992 al 1998 ha svolto incarichi presso consultori familiari della Regione Liguria .

Nel 1999-2000 ha condotto l’ambulatorio di Infertilità dell’AIED di Genova.

Dal Luglio 2001 Dirigente Medico-Disciplina Ginecologia e Ostetricia, per il Centro di Fisiopatologia della Riproduzione dell’Università di Genova – UO Ostetricia e Ginecologia Ospedale San Martino di Genova.

Incarichi di insegnamento

Anni accademici 1997/98 – 2002/2003 incarico di insegnamento presso la scuola di specializzazione in Ostetricia e Ginecologia dell’Università di Genova per il corso integrativo di “Laparoscopia in Ginecologia : tecniche ed indicazioni”

Anni accademici da 2003/2004 a 2008-2009 incarico di insegnamento presso la scuola di specializzazione in Ostetricia e Ginecologia dell’Università di Genova per il corso integrativo di “Tecniche di Riproduzione Assistita”

Iscrizione a Società Scientifiche

Eshre (European Society of Human Reproduction and Embriology)

Esge (European Society of Gynaecological Endoscopy) socio fondatore

Sifes (Società Italiana di Fertilità e Sterilità) membro del direttivo

SidR (Società Italiana della Riproduzione)

Attività Scientifica

Relatore in 42 Convegni nei Settori della fisiopatologia della riproduzione e della chirurgia endoscopica.

Membro dell’Editorial Board della rivista Repronews (Organo della SidR)

Autrice di 49 pubblicazioni su riviste internazionali

Estratto delle principali pubblicazioni Scientifiche

  1. GnRH analogue remarkably down-regulates inflammatory proteins in peritoneal fluid proteome of women with endometriosis.

    Ferrero S, Gillott DJ, Remorgida V, Anserini P., Ragni N, Grudzinskas JG. J Reprod Med. 2009 Apr;54(4):223-31.

  2. Proteomic analysis of peritoneal fluid in fertile and infertile women with endometriosis.

    Ferrero S, Gillott DJ, Remorgida V, Anserini P., Ragni N, Grudzinskas JG. J Reprod Med. 2009 Jan;54(1):32-40.

  3. Peritoneal fluid proteome in women with different ASRM stages of endometriosis.

    Ferrero S, Gillott DJ, Remorgida V, Anserini P., Ragni N, Grudzinskas JG. Gynecol Endocrinol. 2008 Aug;24(8):433-41.

  4. Fertility after bowel resection for endometriosis.

    Ferrero S, Anserini P., Abbamonte LH, Ragni N, Camerini G, Remorgida V. Fertil Steril. 2009 Jul;92(1):41-6.

  5. Increased expression of one isoform of leucine-rich alpha-2-glycoprotein in peritoneal fluid of women with uterine leiomyomas.

    Ferrero S, Gillott DJ, Remorgida V, Anserini P., Ragni N, Grudzinskas JG. Arch Gynecol Obstet. 2009 Mar;279(3):365-71.

  6. A prospective, randomised, controlled clinical study on the assessment of tolerability and of clinical efficacy of Merional (hMG-IBSA) administered subcutaneously versus Merional administered intramuscularly in women undergoing multifollicular ovarian stimulation in an ART programme (IVF).

    Alviggi C, Revelli A, Anserini P., Ranieri A, Fedele L, Strina I, Massobrio M, Ragni N, De Placido G. Reprod Biol Endocrinol. 2007 Dec 4;5:45.

  7. Strategies to minimize discomfort during diagnostic hysterosalpingography with disposable balloon catheters: a randomized placebo-controlled study with oral nonsteroidal premedication.

    Anserini P., Delfino F, Ferraiolo A, Remorgida V, Menoni S, De Caro G. Fertil Steril. 2008 Sep;90(3):844-8. Epub 2007 Oct 22.

  8. Proteomic analysis of peritoneal fluid in women with endometriosis.

    Ferrero S, Gillott DJ, Remorgida V, Anserini P., Leung KY, Ragni N, Grudzinskas JG. J Proteome Res. 2007 Sep;6(9):3402-11. Epub 2007 Aug 3.

  9. Hydrothorax following ovarian hyperstimulation for assisted reproduction. Case report and review of the literature.

    Abbamonte LH, Remorgida V, Ferrero S, Ragni N, Anserini P..Minerva Ginecol. 2007 Feb;59(1):85-90. Review. English, Italian.

  10. Images of children born following infertility treatment.

    Ferrero S, Abbamonte LH, Remorgida V, Anserini P., Ragni N. Arch Gynecol Obstet. 2007 Feb;275(2):113-6. Epub 2006 Aug 22.

  11. Atherosclerosis in women with endometriosis.

    Pretta S, Remorgida V, Abbamonte LH, Anserini P., Ragni N, Del Sette M, Gandolfo C, Ferrero S. Eur J Obstet Gynecol Reprod Biol. 2007 Jun;132(2):226-31.

  12. What is the desired menstrual frequency of women without menstruation-related symptoms?

    Ferrero S, Abbamonte LH, Giordano M, Alessandri F, Anserini P., Remorgida V, Ragni N.Contraception. 2006 May;73(5):537-41.

  13. Total and active ghrelin levels in women with polycystic ovary syndrome.

    Ferrero S, Anserini P., Remorgida V, Bentivoglio G, Ragni N. Hum Reprod. 2006 Feb;21(2):565.

  14. Future perspectives in the medical treatment of endometriosis.

    Ferrero S, Abbamonte LH, Anserini P., Remorgida V, Ragni N.Obstet Gynecol Surv. 2005 Dec;60(12):817-26. Review

  15. Asthma in women with endometriosis.

    Ferrero S, Petrera P, Colombo BM, Navaratnarajah R, Parisi M, Anserini P., Remorgida V, Ragni N. Hum Reprod. 2005 Dec;20(12):3514-7.

  16. Is VEGF a marker for ovarian response and pregnancy outcome?

    Ferrero S, Belluti A, Anserini P., Remorgida V, Ragni N.Eur J Obstet Gynecol Reprod Biol. 2005 Aug 1;121(2):249; author reply 250.

  17. Body mass index in endometriosis.

    Ferrero S, Anserini P., Remorgida V, Ragni N. Eur J Obstet Gynecol Reprod Biol. 2005 Jul 1;121(1):94-8.

  18. How complete is full thickness disc resection of bowel endometriotic lesions? A prospective surgical and histological study.

    Remorgida V, Ragni N, Ferrero S, Anserini P., Torelli P, Fulcheri E. Hum Reprod. 2005 Aug;20(8):2317-20.

  19. Haptoglobin beta chain isoforms in the plasma and peritoneal fluid of women with endometriosis.

    Ferrero S, Gillott DJ, Remorgida V, Anserini P., Price K, Ragni N, Grudzinskas JG. Fertil Steril. 2005 May;83(5):1536-43.

  20. Vitamin D binding protein in endometriosis.

    Ferrero S, Gillott DJ, Anserini P., Remorgida V, Price KM, Ragni N, Grudzinskas JG. J Soc Gynecol Investig. 2005 May;12(4):272-7.

  21. The 2004 Italian legislation regulating assisted reproduction technology: a multicentre survey on the results of IVF cycles.

    Ragni G, Allegra A, Anserini P., Causio F, Ferraretti AP, Greco E, Palermo R, Somigliana E. Hum Reprod. 2005 Aug;20(8):2224-8. Epub 2005 Apr 7.

  22. Quality of sex life in women with endometriosis and deep dyspareunia.

    Ferrero S, Esposito F, Abbamonte LH, Anserini P., Remorgida V, Ragni N. Fertil Steril. 2005 Mar;83(3):573-9.

  23. Hysterosalpingography with gadolinium.

    De Caro G, Ferraiolo A, Castelletti L, Anserini P., Gorlero F. Eur Radiol. 2005 Jul;15(7):1469-71.

  24. The involvement of the interstitial Cajal cells and the enteric nervous system in bowel endometriosis.

    Remorgida V, Ragni N, Ferrero S, Anserini P., Torelli P, Fulcheri E. Hum Reprod. 2005 Jan;20(1):264-71.

  25. Increased frequency of migraine among women with endometriosis.

    Ferrero S, Pretta S, Bertoldi S, Anserini P., Remorgida V, Del Sette M, Gandolfo C, Ragni N. Hum Reprod. 2004 Dec;19(12):2927-32.

  26. "Triple marker" for ectopic pregnancy.

    Ferrero S, Anserini P., Remorgida V, Ragni N. Fertil Steril. 2004 Oct;82(4):986; author reply 986-7.

  27. Methodological concerns regarding levels of vascular endothelial growth factor (VEGF) in serum of patients with endometriosis.

    Ferrero S, Gillott DJ, Anserini P., Remorgida V, Teisner B, Grudzinskas JG. Hum Reprod. 2004 Jan;19(1):220-1; author reply 221.

  28. Semen analysis following allogeneic bone marrow transplantation. Additional data for evidence-based counselling.

    Anserini P., Chiodi S, Spinelli S, Costa M, Conte N, Copello F, Bacigalupo A. Bone Marrow Transplant. 2002 Oct;30(7):447-51.

  29. [Luteal phase support in assisted reproductive cycles using either vaginal (Crinone 8) or intramuscular (Prontogest) progesterone: results of a prospective randomized study]

    Anserini P., Costa M, Remorgida V, Sarli R, Guglielminetti E, Ragni N.Minerva Ginecol. 2001 Aug;53(4):297-301. Italian.

  30. A prospective, randomized, controlled clinical study of a new subcutaneous, purified, urinary FSH preparation for controlled ovarian hyperstimulation in in vitro fertilization.

    Anserini P., Costa M, Remorgida V, Venturini PL. Gynecol Endocrinol. 2000 Apr;14(2):75-80.

  31. Four year experience in laparoscopic dissection of intact ovarian dermoid cysts.

    Remorgida V, Magnasco A, Pizzorno V, Anserini P.. J Am Coll Surg. 1998 Nov;187(5):519-21.

  32. Comparison of a blocking vs. a flare-up protocol in poor responders with a normal and abnormal clomiphene citrate challenge test.

    Anserini P., Magnasco A, Remorgida V, Gaggero G, Testa D, Capitanio GL. Gynecol Endocrinol. 1997 Oct;11(5):321-6.

  33. Intrauterine insemination with husband's semen as alternative to other assisted reproduction techniques.

    Ferraro F, Costa M, Ferraiolo A, Anserini P., Remorgida V, Capitanio G. Acta Eur Fertil. 1995 Mar-Apr;26(2):63-7.

  34. Laparoscopic surgery in pregnancy. A case report with a brief review of the topic.

    Remorgida V, Carrer C, Ferraiolo A, Natucci M, Anserini P.. Surg Endosc. 1995 Feb;9(2):195-6. Review.

  35. Transcervical selective salpingography: a diagnostic and therapeutic approach to cases of proximal tubal injection failure.

    Capitanio GL, Ferraiolo A, Croce S, Gazzo R, Anserini P., de Cecco L. Fertil Steril. 1991 Jun;55(6):1045-50.

  36. 'Blind' transcervical transfer of gametes in the fallopian tube: a preliminary study.

    Ferraiolo A, Croce S, Anserini P., Remorgida V, Lanera P, Capitanio GL, de Cecco L. Hum Reprod. 1991 Apr;6(4):537-40.

  37. Transabdominal and transvaginal ultrasonographic diagnosis of ectopic pregnancy: clinical implications.

    Valenzano M, Anserini P., Remorgida V, Brasca A, Centonze A, Costantini S. Gynecol Obstet Invest. 1991;31(1):8-11.

  38. Use of combined exogenous gonadotropins and pulsatile gonadotropin-releasing hormone in patients with polycystic ovarian disease.

    Remorgida V, Venturini PL, Anserini P., Salerno E, de Cecco L. Fertil Steril. 1991 Jan;55(1):61-5. Erratum in: Fertil Steril 1991 Jun;55(6):1213.

  39. Treatment of endometriosis with goserelin depot, a long-acting gonadotropin-releasing hormone agonist analog: endocrine and clinical results.

    Venturini PL, Fasce V, Costantini S, Anserini P., Cucuccio S, de Cecco L. Fertil Steril. 1990 Dec;54(6):1021-7.

  40. Naltrexone in functional hypothalamic amenorrhea and in the normal luteal phase.

    Remorgida V, Venturini PL, Anserini P., Salerno E, De Cecco L. Obstet Gynecol. 1990 Dec;76(6):1115-20.

  41. Comparison of different ovarian stimulation protocols for gamete intrafallopian transfer in patients with minimal and mild endometriosis.

    Remorgida V, Anserini P., Croce S, Costa M, Ferraiolo A, Capitanio GL. Fertil Steril. 1990 Jun;53(6):1060-3.

  42. The duration of pituitary suppression by means of intranasal gonadotropin hormone-releasing hormone analogue administration does not influence the ovarian response to gonadotropin stimulation and success rate in a gamete intrafallopian transfer (GIFT) program.

    Remorgida V, Anserini P., Croce S, Costa M, Ferraiolo A, Centonze A, Gaggero G, Capitanio GL. J In Vitro Fert Embryo Transf. 1989 Apr;6(2):76-80.

  43. Early progesterone rise during ovarian stimulation in humans: difference with the primate model.

    Remorgida V, Anserini P., Venturini PL, De Cecco L. Horm Metab Res. 1989 Feb;21(2):108.

  44. Administration of pure follicle-stimulating hormone during gonadotropin-releasing hormone agonist therapy in patients with clomiphene-resistant polycystic ovarian disease: hormonal evaluations and clinical perspectives.

    Remorgida V, Venturini PL, Anserini P., Lanera P, De Cecco L. Am J Obstet Gynecol. 1989 Jan;160(1):108-13.

  45. Gamete intrafallopian transfer and plasma chorionic gonadotropin dynamics: evidence of a delayed appearance.

    Remorgida V, Anserini P., Costa M, Gaggero G, Croce S, Capitanio GL. J In Vitro Fert Embryo Transf. 1988 Aug;5(4):195-8.